Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

(MedPage Today) -- The investigational orexin receptor 2 (OX2R) agonist oveporexton improved cognitive symptoms of narcolepsy type 1 (NT1) in secondary analysis of a phase II trial.
The oral agent improved attention, memory, and executive function...